Ingredient or product comparison
GHK-Cu vs Minoxidil Mechanism: Full Pathway Comparison
Primary molecular target Integrin receptors (α2β1, α3β1) on keratinocytes and fibroblasts ATP-sensitive K+ channels in vascular smooth muscle Completely distinct. No receptor overlap or competitive binding Cellular entry method Receptor-mediated endocytosis Pa
This source-based comparison does not add ratings or recommend a winner.
- Primary molecular target
- Integrin receptors (α2β1, α3β1) on keratinocytes and fibroblasts
- ATP-sensitive K+ channels in vascular smooth muscle
- Completely distinct. No receptor overlap or competitive binding
- Cellular entry method
- Receptor-mediated endocytosis
- Passive diffusion across lipid membranes (sulfate form)
- GHK-Cu requires active transport; minoxidil crosses membranes freely
- Time to initial molecular effect
- 6–12 hours (gene transcription)
- 30–90 minutes (ion channel opening)
- Minoxidil acts faster at membrane level; GHK-Cu requires transcriptional lag
- Angiogenic pathway
- VEGF upregulation via HIF-1α transcription factor activation
- Vasodilation via smooth muscle relaxation (no new vessel formation)
- GHK-Cu stimulates angiogenesis; minoxidil only increases flow through existing vessels
- Dependence on endogenous enzymes
- Requires bioavailable copper ions as cofactor
- Requires sulfotransferase to convert minoxidil → minoxidil sulfate
- Both are prodrugs requiring enzymatic activation. Non-responders exist for each
- Effect on extracellular matrix
- Increases collagen/elastin cross-linking via lysyl oxidase activation
- No direct ECM effect
- Only GHK-Cu rebuilds follicular structural support
- Anti-fibrotic activity
- Inhibits TGF-β1 signaling (reduces follicular miniaturization)
- No documented anti-fibrotic mechanism
- GHK-Cu addresses the fibrotic component of androgenetic alopecia; minoxidil does not